Gracell gives sneak peek into leukemia CAR-T cell program ahead of EHA
Gracell Biotechnologies said Thursday afternoon that its CAR-T treatment for patients with B cell acute lymphoblastic leukemia, or B-ALL, helped clear signs of cancer in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.